- ALL
- Food Regulations and Standards——Latest Progress in Regulations and Standards
- Food Regulations and Standards——Current Status and Challenges of Food Claims
- Foods for Special Medical Purposes (FSMPs)——Accelerating Market Access to Improve the Availability of Special Medical Foods
- Foods for Special Medical Purposes (FSMPs)——Industry Empowerment:New Perspectives on Medical Food
- Foods for Special Medical Purposes (FSMPs)——Roundtable Meeting
Sessions
Section I:Food Regulations and Standards——Session 1:Latest Progress in Regulations and Standards |
2026-03-12 14:00-16:50 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
Moderator:Huo Junsheng,Research Fellow,National Institute for Nutrition and Health,Chinese Center for Disease Control and Prevention |
| 2026-03-12 14:00-14:20 Challenges and Reflections on the Administration of Infant Formula and Medical FoodsDepartment of Supervision and Administration of Special Food Safety of the State Administration for Market Regulation |
| 2026-03-12 14:20-14:40 New Progress in the Administration of Health FoodsDepartment of Supervision and Administration of Special Food Safety of the State Administration for Market Regulation |
| 2026-03-12 14:40-15:00 Practice in the Evaluation of New Functions of Health FoodsLiu Hongyu,Division Director,Food Evaluation Center of the State Administration for Market Regulation |
| 2026-03-12 15:00-15:20 Development of the List of Health Food Raw MaterialsSayi,Director of the Health Food Safety Evaluation Department,Food Evaluation Center,National Market |
| 2026-03-12 15:20-15:35 Reflections on the R&D of Milk Components and the Formulation of Their StandardsWang Jun Research Fellow,China National Center for Food Safety Risk Assessment |
| 2026-03-12 15:35-15:50 Latest Updates on Food Standards for Special Medical Purposes (FSMP)Fang Haiqin Researcher,Nutrition Room 1，China National Center for Food safety Risk AssessmentDirector |
| 2026-03-12 15:50-16:05 Policy Practice of Temporary Import of Food for Special Medical Purposes (FSMP) and Health Food in Hainan Boao Lecheng Pilot ZoneWanshuang,Director of Pharmaceutical and Medical Device Department,Boao Lecheng International Medical Tourism Pilot Zone Administration,Hainan |
| 2026-03-12 16:05-16:40 Q&AModerator: |
Section V:Foods for Special Medical Purposes (FSMPs)——Session 1:Accelerating Market Access to Improve the Availability of Special Medical Foods |
2026-03-13 13:00-14:30 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
Moderator：Fang Haiqin Research Fellow,China National Center for Food Safety Risk Assessment,Chief Researcher |
| 2026-03-13 13:00-13:15 Guiding Report:A Decade of Development Review and Future Outlook for Food for Special Medical Purposes (FSMP) |
| 2026-03-13 13:15-13:30 Development Trends and Challenges in the Application Policies for Foods for Special Medical Purposes (FSMP) |
| 2026-03-13 13:30-13:45 Market Access Status and Channels of Medical Food Products in Europe |
| 2026-03-13 13:45-14:00 Learning from Other Asia Pacific Countries:Application of FSMP in Singapore and Australia |
| 2026-03-13 14:00-14:15 Metabolic Modulation:The Path of Nutritional Intervention in Disease Prevention and Treatment |
| 2026-03-13 14:15-14:30 Medical Food in Taiwan:Marketing Strategies Under Stringent Regulatory Framework |
Section V:Foods for Special Medical Purposes (FSMPs)——Session 2:Industry Empowerment:New Perspectives on Medical Food |
2026-03-13 14:40-16:25 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
Moderator：Fang Haiqin Research Fellow,China National Center for Food Safety Risk Assessment,Chief Researcher |
| 2026-03-13 14:40-14:55 Food for Special Medical Purpose 2.0:The Era of Real Food |
| 2026-03-13 14:55-15:10 Clinical Practice and Existing Challenges of Partially Hydrolyzed Protein-Based Formulas |
| 2026-03-13 15:10-15:25 Specific nutrition formulation (Fortasyn Connect) with proven clinical benefits in preventing memory decline in aMCI / early AD) |
| 2026-03-13 15:25-15:40 Design Strategies for Special Nutritional Products Targeting Blood Glucose Management in Patients with Renal Dialysis Requirements |
| 2026-03-13 15:40-15:55 The Role of Custom-Tailored and Optimized Whey Protein Formulas in Nutritional Management of Chronic Kidney Disease (CKD) |
| 2026-03-13 15:55-16:10 Caseinates in medical nutrition:indispensable and versatile |
| 2026-03-13 16:10-16:25 Latest Evidence for Oral Nutrition Solutions (ONS) for Oncology:Benefits of high protein and omega-3 enriched ONS on outcomes in cancer patients undergoing treatment. |
Section V:Foods for Special Medical Purposes (FSMPs)——Roundtable Meeting |
2026-03-13 16:30-17:00 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
| 2026-03-13 16:30-17:00 Roundtable Meeting:Discussing the Future of Specialty Medicine:How do you envision the future of specialty medicine in China,and what are some of the pressing issues that need to be addressed?Moderator: |
Innovation Forum：Real Human Scientific Testing for Health Foods – A Data-Driven Innovation Solution |
2026-03-14 09:00-11:15 Dongyu,Changyan room(Wanquan Ballroom 1/3) |
Supported by:Yiwi Testing & Evaluation (Shanghai) Co.,Ltd.;Hainan Huayan collagen Technology Co.,Ltd., |
Clinical Trial Launch Ceremony and Product Launch for the "Nannochloropsis Oculata and Turmeric Beverage Combination" |
| 2026-03-14 09:15-09:35 Imaging Diagnosis and Clinical Management of Pulmonary NodulesWang Song,Chief Physician,Longhua Hospital Shanghai University of Traditional Chinese Medicine |
| 2026-03-14 09:35-09:55 Research on the Synergistic Effects of Nutrient Combinations |
| 2026-03-14 09:55-10:15 Standardized Evaluation of Food-as-Medicine Products:Clinical Trial Exploration in a Pulmonary Nodule Population |
| 2026-03-14 10:15-10:35 Cross-Border Integration of Pharmaceutical and Food Industries： Innovative Paths and Practical Applications — Collagen Cyclic Dipeptides |
| 2026-03-14 10:35-10:55 From "Experience-Driven"to "Evidence-Driven":Building a New Hanfang Brand from a Global Perspective |
| 2026-03-14 10:55-11:15 Evidence-Based Assessment of Fresh Collagen for Oral Beauty Therapy |
| 2026-03-14 11:15-11:35 Complete a true closed-loop validation through real-world consumer scenarios |